NCT00399711 · Interventional trial
Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes
Overall registry status Completed
Phase 3
Conditions Diabetes, Diabetes Mellitus, Type 2
Delaware Valley sites
- Novo Nordisk Investigational Site · Berlin, NJ · Camden County
- Novo Nordisk Investigational Site · Norristown, PA · Montgomery County
- Novo Nordisk Investigational Site · Philadelphia, PA · Philadelphia County
- Novo Nordisk Investigational Site · Springfield, PA · Delaware County
First posted
Registry updated
Added to the directory